Javascript must be enabled to continue!
A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma
View through CrossRef
Abstract
Introduction:
CD30+ primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a rare T-cell neoplasm, and has been reported to present with an indolent behavior. The PC-ALCL with aggressive behavior has not been reported in the literature.
Patient concerns:
We treated a patient with PC-ALCL that exhibited indolent behavior in the past 2 years and aggressive behavior within the last 3 months before presentation.
Diagnosis:
Aggressive CD30+ primary cutaneous anaplastic large cell lymphoma.
Interventions:
The radiotherapy regimen was individualized in terms of the target volume delineation and dose prescription, and the dose–response relationship was evaluated.
Outcomes:
The mean distance of microscopic infiltration was 14.1 mm in depth and 14.3 mm circumferentially. The lesion completely regressed after the delivery of 40 Gy in 20 fractions over 4 weeks. The tumor did not recur over the next year.
Conclusion:
An aggressive disease course is rare for indolent CD30+ PC-ALCL, which has similar histopathological characteristics as indolent PC-ALCL. The radiotherapy strategy should be individualized with curative intent.
Ovid Technologies (Wolters Kluwer Health)
Title: A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma
Description:
Abstract
Introduction:
CD30+ primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a rare T-cell neoplasm, and has been reported to present with an indolent behavior.
The PC-ALCL with aggressive behavior has not been reported in the literature.
Patient concerns:
We treated a patient with PC-ALCL that exhibited indolent behavior in the past 2 years and aggressive behavior within the last 3 months before presentation.
Diagnosis:
Aggressive CD30+ primary cutaneous anaplastic large cell lymphoma.
Interventions:
The radiotherapy regimen was individualized in terms of the target volume delineation and dose prescription, and the dose–response relationship was evaluated.
Outcomes:
The mean distance of microscopic infiltration was 14.
1 mm in depth and 14.
3 mm circumferentially.
The lesion completely regressed after the delivery of 40 Gy in 20 fractions over 4 weeks.
The tumor did not recur over the next year.
Conclusion:
An aggressive disease course is rare for indolent CD30+ PC-ALCL, which has similar histopathological characteristics as indolent PC-ALCL.
The radiotherapy strategy should be individualized with curative intent.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Introduction:
The incidence of lymphoma has been increasing over the past several decades, with data showing an estimated annual percentage change of 0.56%. There...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Real-World Results of Brentuximab Vedotin Containing Regimens in CD30 Positive Lymphoma: A Single-Center Retrospective Study
Real-World Results of Brentuximab Vedotin Containing Regimens in CD30 Positive Lymphoma: A Single-Center Retrospective Study
Objective:
The objective of this retrospective study was to assess the effectiveness and safety of Brentuximab Vedotin (BV) in CD30-positive lymphoma.
...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Rapidly fatal anaplastic CD30+ primary cutaneous T-cell lymphoma: about a case
Rapidly fatal anaplastic CD30+ primary cutaneous T-cell lymphoma: about a case
CD30+ anaplastic primary cutaneous T-cell lymphoma is a type of cutaneous lymphoma rarely described in the literature and has an exceptional disseminated tumor form. This was a 73-...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...

